Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell...

61

Transcript of Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell...

Page 1: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.
Page 2: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Knee OA

Evaluation of treatment with orthotics

(wedged insole and knee brace)

Preliminary data

Kjell G Nilsson, MD, PhD, FRACSJan Karlsson, CPO

Department of OrthopaedicsUmeå University hospital

Umeå, Sweden

Page 3: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Implant Research Unit

Osteoarthrosis (OA) OA is a very common disease More common than diabetes and heart diseases Incidence increases with age However, common even in younger patients

• approx 5 % between 35 och 54 years have OA

Page 4: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

30 40 50 60 70 800

10

20

30

40

50

60

70

80

90

Age

Hip OA

Knee OA

Finger OA

Prevalence of OA (%)

Page 5: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Implant Research Unit

OA

Cost for the society (Sweden 2002)• Direct costs (drugs and treatmenmt)

– 2 billion SEK

• Sick leave and loss of income and loss of production

– 10 billion SEK

Page 6: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Symptoms of OA at the knee

Often insidious onset

Stiffness

Decreased mobility and range of motion

Crepitations

Pain with activity

Swelling

Tenderness

Pain at rest

Deformity

Page 7: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Implant Research Unit

Page 8: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Treatment of OA

Few

Some

All

?

Page 9: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Treatment of knee OA with orthotics

• Wedged insole (keel)• Brace

Suggested function:• Reduce the load on the concave side of the deformity

during weight bearing (“dynamic unloading”)

reduce pain

Page 10: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Wedged insole

Suggested function Reduce the load (varus moment) lateral keel reduce pain

Page 11: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Suggested function

Reduce the load

(varus moment)

keel + valgusbrace

(three point pinciple)

reduce pain

Wedged insole + brace

Page 12: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Treatment of knee OA with orthotics

• Several studies have shown biomechanical effects of wedged insoles and knee braces

But

• What about their clinical effects??

Page 13: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.
Page 14: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.
Page 15: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Questions

• What are the effects (if any) (as measured by KOOS) of– 1. Wedged insole (keel) only– 2. Wedged insole (keel) + varus or valgus brace

• Do all patients require brace? Or is insole sometimes enough?

• Are there gender differences?• Are there age differences?

Page 16: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Knee Injury and Osteoarthritis Outcome Score (KOOS)• A knee specific instrument• Consists of 5 subscales

– 1. Pain 9 questions– 2. Other symptoms 7 questions

» (swelling, joint movement, mechanical symptoms)

– 3. Function in daily living (ADL) 17 questions– 4. Function in sports and recreation 5 questions– 5. Knee related Quality of Life (QoL) 4

questions• Each answer alternative is scored 0 to 4

Roos, Lohmander et al, Health Qual Life Outcomes 2003:1:64Roos, Roos, Lohmander et al, Scand J Med Sci Sports 1998:8:439Roos, Roos, Lohmander et al, J Orthop Sports Phys Ther 1998:28:88

Page 17: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

KOOS

• All scores for each subscale are summarized and thereafter normalized to a 0-100 scale– 0 extreme knee symptoms– 100 no knee symptoms

• A total score for all 5 subscales is NOT calculated

Page 18: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

KOOS

• Change over time “Effect Size”

(After – Before)/SD (Before)

Before treatment

After treatment

After

Before

Page 19: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Arthroplasty ACL reconstr Meniscectomy ACI

0.0

0.5

1.0

1.5

2.0

2.5

3.0

painsymptomsADLSportsRecrQoL

Effect size, examples

Page 20: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Present Study

1. Initially, offer all patients a laterally or medially wedged insoleFollow up minimum 6 weeks

2. For those who are unsatisfied with insole, offer a knee brace in addition to insoleFollow up minimum 6 weeks

3. (Plan: Continued follow up of all patients > 5 years)

Page 21: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Patient logistics (1)

• Referred from the Orthopaedic Department• Medial or lateral OA as confirmed by X ray• Clinical symptoms of OA• No inflammatory arthritis

• For various reasons not ready for surgery– (Too young, too old, too infirm, not mentally ready for

surgery, want to try conservative treatment before accepting operation, etc…)

Page 22: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Methods (1)

• 1. After receiving the referral– Information letter and 1st KOOS questionnaire sent to the patient– KOOS form to be filled out before first visit

• 2. First visit– 1st KOOS form collected (i.e. PRE treatment form)– Repeat information about the study– 10 degree laterally or medially wedged insole (keel) given to all

patients– 2nd KOOS form given, to be sent back after ≥ 6 weeks of insole/keel

treatment (i.e. keel/insole form)– Asked to indicate after 6 weeks if insole/keel treatment is sufficient

or insufficient

Page 23: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Methods (2)

• Second visit (for those patients who felt insole/keel treatment was insufficient)– All these patients received a varus or valgus brace to be used in

addition to the wedged insole/keel– Given a 3rd KOOS form (insole/keel-brace form) to be filled in after ≥

6 weeks of treatment with insole/keel + brace treatment

Page 24: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Patient logistics (2)

136 referralsreceived

120 KOOS formscorrectly filled out

90 KOOS formsreceived after 6 weeks

treatment with insole/keel

Insole/keel treatment

56 patients satisfiedwith insole/keel

treatment

34 patients NOT satisfiedwith insole/keel treatment

Addition ofbrace

34 KOOS forms received after 6 weeksof insole/keel treatment

Page 25: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Patients

• N = 90, mean age 58 y– 47 men (mean 56 y)– 43 women (mean 60 y)

• (Bilat OA n=19) - (10 men, 9 women)

• Medial – (38 men, 36 women)

• Lateral OA n=16 (18%) - (9 men, 7 women)

Page 26: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Inlay sole:10° laterally or medially based keel

Page 27: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Braces used

Page 28: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Custom CarbonFibre

1 patient

Page 29: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

DonJoy (11-0872)

1 patient

Page 30: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Camp (Breg 0700, Breg 25262)

8 patients

Page 31: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Custom, DonJoy, Camp

• Difficult to adjust to the patients• Felt by the patient to be “bulky”• Relatively small pads for soft tissue pressure

• Abandoned after 10 patients

Page 32: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Össur Unloader One

24 patients

Page 33: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Össur Unloader One

• Large pads for soft tissue contact and pressure• Easy to adjust to the individual patient• Easy to apply and remove• Easily accepted by the patient

• Therefore used in the majority of the patients (the last 24)

Page 34: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Preliminary data

Page 35: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Effect of a wedged insole

Page 36: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel

0.05 ns ns ns 0.003

Insole/Keel (90 patients)

Paired t test

Mean values ± 95% CI

Page 37: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel

ns ns ns ns ns

Insole/Keel(women)

Paired t test

Mean values ± 95% CI

Page 38: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel

0.01 ns ns ns 0. 002

Insole/Keel(men)

Paired t test

Mean values ± 95% CI

Page 39: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Summary: Effects of Insole/Keel

• Some improvement in total material

– Effect size 0.10 (symptoms) to 0.31 (QoL)

• Smaller effect in women– Effect size 0.05 (symptoms) to 0.27

(QoL)

• Larger effect in men– Effect size 0.10 (symptoms) to 0.55

(QoL)

Keel all Keel women Keel men

0.0

0.2

0.4

0.6

0.8

1.0

painsymptomsADLSportsRecrQoL

Page 40: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Men Pre

Men Keel

Women Pre

Women Keel

Women vs menw and w/o insole/keel

0.02 0.006 0.04 0.17 0.45Women keel vs men keel

0.17 0.004 0.09 0.11 0.81Women pre vs men pre

Un-paired t test

Page 41: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Effects of insole/keel and age

Page 42: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel

ns ns ns ns ns

Insole/Keel(age < 60 years)

Paired t test

Mean values ± 95% CI

Page 43: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel

0.04 ns 0.04 ns 0.001

Insole/Keel(age > 60 years)

Paired t test

Mean values ± 95% CI

Page 44: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Summary: Effects of Insole/Keel and Age

• Small effect in the young (< 60 years)

– Effect size 0.00 (symptoms) to 0.17 (sports/recr)

• Larger effect in the elderly (> 60 years)

– Effect size 0.19 (sports/recr) to 0.64 (QoL)

Keel young Keel old

0.0

0.2

0.4

0.6

0.8

1.0

painsymptomsADLSportsRecrQoL

Page 45: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Results after 6 weeks of insole/keel

• 56 patients were satisfied• 34 patients were dissatisfied

• Question: • Was there a difference in KOOS between those groups?

Page 46: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Satisfied vs dissatisfied after 6w with insole/keel

56 Satisfied with keel

34 Dissatisfied with keel

0.02 0.28 0.08 0.71 0.02 Un-paired t test

Page 47: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Effects of insole/keel and brace

Page 48: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel + orthosis

0.9 0.02 0.048 0.04 0.01

Keel + Brace (34 patients)

Paired t test

Mean values ± 95% CI

Page 49: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel + orthosis

0.29 0.32 0.30 0.53 0.54

Keel + Brace (34 patients)

Effect Size:

Page 50: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Summary: Effects of Keel and Brace

• Significant improvement of all 5 subscales of KOOS– Effect size 0.29 (pain) to 0.54 (QoL)

Page 51: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Effects of keel and braceand age

Page 52: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

Pre

Keel + orthosis

0.04 0.01 0.01 0.01 0.002

Keel + Brace (< 60 years)

Paired t test

Mean values ± 95% CI

Page 53: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Pain Symptoms ADL Sports QoL

100

80

60

40

20

0

ns ns ns ns ns

Pre

Keel + orthosis

Keel + Brace (> 60 years)

Paired t test

Mean values ± 95% CI

Page 54: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Keel+Brace young Keel+Brace old

0.0

0.2

0.4

0.6

0.8

1.0

painsymptomsADLSports/RecrQoL

Summary: Effects of Keel and Brace and Age• Highly significant

improvement in all 5 subscales in younger patients (< 60 y)

– Effect size 0.45 (symptoms) to 0.87 (sports/recr)

• No significant effect in older patients (>60 y)

– Effect size -0.27 (sports/recr) to 0.12 (symptoms)

Keel+Brace old

Page 55: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Effect size, examples

MeniscectomyKeel old

Keel youngKeel+Brace old

Keel+Brace young

0.0

0.2

0.4

0.6

0.8

painsymptomsADLSportRecrQoL

Keel+Brace old

Effect size summary

Page 56: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Discussion (1)

• This study shows that orthotics indeed are effective in treating OA

• There was improvement in every domain/subscale of KOOS with treatment

• However, it seems that there are differences in the results, not at least as regards the age of the patient

Page 57: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Discussion (2)

• A wedged insole (keel) can be used to start treatment– Easy– Cheap– Sufficient for > 50% of the patients (56 of 90)– Especially for elderly patients– Effect size in elderly similar to meniscectomy

Page 58: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Discussion (3)

• If a wedged insole is insufficient, addition of a brace is beneficial, provided the patient is younger

• Effect size in the younger patient larger than for meniscectomy

Page 59: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Discussion (4)

• As in other studies of patients with symptoms of OA, female patients score lower values for all items of the KOOS questionnaire

Page 60: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.

Discussion (5)

So far unanswered questions:• How long will the improvement last?• Differences among insole only compared to insole+brace?• Will the patients continue to use their insoles/braces• What about compliance?• How many of these patients will go on having knee

arthroplasty in the future?

Page 61: Knee OA Evaluation of treatment with orthotics (wedged insole and knee brace) Preliminary data Kjell G Nilsson, MD, PhD, FRACS Jan Karlsson, CPO Department.